Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancerXiaoqing Jia, Guang‐Yu Liu|Oncotarget|2015Cited by 37
Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in�vivoXiaoqing Jia, Guang‐Yu Liu|Molecular Medicine Reports|2018Cited by 5